Strive, Inc. · NASDAQ:ASST
Strive — Strive Asset Management — Merger or Acquisition (May 2025)
9 slides from Strive's merger presentation, May 2025
Slide 1: Strive Asset Management May 2025
/ 7 STRIVE ASSET MANAGEMENT / May 2025
Slide 2: Cautionary Statement Regarding Forward-Looking Statements
Cautionary Statement Regarding Forward-Looking Statements Certain statements herein and the documents incorporated herein by reference may constitute “forward -looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, a
Slide 3: Strive Asset Management Is Already Executing Ahead of Schedule From Merger Announcement
STRIVE ASSET MANAGEMENT IS ALREADY EXECUTING AHEAD OF SCHEDULE FROM MERGER ANNOUNCEMENT WITH ASSET ENTITIES (NASDAQ: ASST) ON MAY 7, 2025 TRANSACTION DETAILS • STRIVE ASSET MANAGEMENT AND ASSET ENTITIES (NASDAQ: ASST) ANNOUNCED $750M PRIVATE INVESTMENT TO FUND FIRST WAVE OF BITCOIN ACCUMULATION • PI
Slide 4: Strive Stands Alone in Seeking Bitcoin Alpha Generation
STRIVE STANDS ALONE IN SEEKING BITCOIN ALPHA GENERATION INCUMBENT BITCOIN TREASURY COMPANIES STRIVE IS POISED TO BECOME THE 1ST MULTI- PROVIDE BITCOIN EXPOSURE THROUGH BETA – STRATEGY ALPHA-GENERATING BITCOIN TREASURY WITH OR WITHOUT LEVERAGE COMPANY BETA-GENERATING BITCOIN TREASURY STRATEGIES STRIV
Slide 5: How Should Investors in a Bitcoin Treasury Company Value Alpha Generation?
HOW SHOULD INVESTORS IN A BITCOIN TREASURY COMPANY VALUE ALPHA GENERATION? 15-Year Dollar Return Multiple on Bitcoin Acquired Through Alpha Strategies Annual Alpha Bitcoin ARR% 0% 1% 2% 3% 4% 5% 0% 1.0x 1.2x 1.3x 1.6x 1.8x 2.1x 10% 1.0x 1.3x 1.7x 2.2x 2.8x 3.4x 20% 1.0x 1.8x 2.7x 3.8x 5.0x 6.5x 30%
Slide 6: Our Plan to Acquire Cash for a Discount in the Biotech Industry
OUR PLAN TO ACQUIRE CASH FOR A DISCOUNT IN THE BIOTECH INDUSTRY Illustrative Biotech The Strive Strategy Scenario 1. EXCHANGE SHARES FOR STRIVE EQUITY Unlike a hedge fund, we can merge the biotech company into Strive and offer • Following a negative clinical readout, shareholders liquid equity. BioC
Slide 7: The Biotech 'Trapped Cash' Landscape: $30BN+ Opportunity
THE BIOTECH ‘TRAPPED CASH’ LANDSCAPE: $30BN+ OPPORTUNITY There are more biotech companies trading at % of SMID-cap Biotech Companies Trading at negative enterprise value now than at any a Negative EV1 other known period in history. 25% 23% 20% 15% 15% 15% 23% 246 ~$32B 12% 10% 7% 7% 5% 2% 2% Biotech
Slide 8: Strategic Opportunity: Distressed Bitcoin Litigation Claims
STRATEGIC OPPORTUNITY: DISTRESSED BITCOIN LITIGATION CLAIMS Strive can generate value by purchasing Bitcoin claims with definitive legal judgments but pending distribution—exemplified by Mt. Gox. These claims trade at a discount to the current Bitcoin market price, producing potential alpha for a lo
Slide 9: Equity Tranches of Structured Bitcoin Can Offer Attractive Returns
EQUITY TRANCHES OF STRUCTURED BITCOIN CAN OFFER ATTRACTIVE RETURNS Strive is in discussions with potential structured At maturity, Bitcoin is used to repay debt and equity Bitcoin originators to purchase bottom tranches of structured Bitcoin at what we expect will be attractive prices to generate lo
Strive Asset Management — Merger or Acquisition (May 2025) on 6ix